LTFS
CUE icon

Ladenburg Thalmann Financial Services’s Cue Biopharma CUE Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio CUE Stock Details CUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$2K Hold
4
– – ﹤0.01% 5045
2019
Q3 		$1K Hold
4
– – ﹤0.01% 5092
2019
Q2 		$1K Hold
4
– – ﹤0.01% 5090
2019
Q1 		$1K Hold
4
– – ﹤0.01% 5057
2018
Q4 		$1K Hold
4
– – ﹤0.01% 5020
2018
Q3 		$1K Hold
4
– – ﹤0.01% 4977
2018
Q2 		$2K Hold
4
– – ﹤0.01% 4848
2018
Q1 		$2K Buy
+4
New +$1.82K ﹤0.01% 4848

Other funds holding CUE

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
CA
Corriente Advisors Fort Worth, Texas $9.53M AUM 805.26% 1-Year Est. Return
CAG
Crestwood Advisors Group Boston, Massachusetts $5.94B AUM 18.44% 1-Year Est. Return

Ladenburg Thalmann Financial Services's CUE Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services held its Cue Biopharma (CUE) position steady in Q4 2019 at 4 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #5045.

Ladenburg Thalmann Financial Services first reported a position in CUE in Q1 2018 and has held it in 8 quarters since. 63 funds tracked by Wall St. Rank hold CUE as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 4 shares of Cue Biopharma worth $2K as of Q4 2019.
  • Ladenburg Thalmann Financial Services left its Cue Biopharma share count unchanged in Q4 2019.
  • Cue Biopharma made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #5045 holding.
  • Ladenburg Thalmann Financial Services first reported a position in Cue Biopharma in Q1 2018 and has held it in 8 quarters since.
  • 63 funds tracked by Wall St. Rank held Cue Biopharma as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.